Biodexa Pharmaceuticals's total assets for Q4 2024 were £14.78M, an increase of 5.81% from the previous quarter. BDRX total liabilities were £6.46M for the fiscal quarter, a 23.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.